NEU 1.79% $15.94 neuren pharmaceuticals limited

There definitely was mate, but from memory, the discussion...

  1. 1,079 Posts.
    lightbulb Created with Sketch. 658
    There definitely was mate, but from memory, the discussion centred around why NEU alone was ill-equipped to handle such an undertaking. Too small, not enough staff, funding, etc etc. BP may have the firepower and resources to do so however, especially if the prize is a world first treatment for ASD. 1 in every few hundred people? Thats an unspeakably large TM. The mind boggles.

    I would add however as someone who works with children with ASD and their families, that a large portion of them would be repelled at the very idea of a 'cure' or even treatment ASD. There is a growing movement looking upon the condition not as a disability, but something else. Not for me to try and elaborate there, but of course other families would be desperate for some help with a condition that can be highly debilitating. Numbers of diagnosed ASD people does not equal number of people seeking treatment is my only (rambling) point.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.94
Change
-0.290(1.79%)
Mkt cap ! $2.037B
Open High Low Value Volume
$16.33 $16.37 $15.78 $10.73M 671.9K

Buyers (Bids)

No. Vol. Price($)
1 1500 $15.90
 

Sellers (Offers)

Price($) Vol. No.
$16.02 1422 2
View Market Depth
Last trade - 16.10pm 13/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.